Ferguson L R, Baguley B C
Cancer Treat Rep. 1984 Apr;68(4):625-30.
The antitumor drug amsacrine causes chromosomal aberrations both in cultured cells (L1210 murine leukemia and HeLa cells) and in vivo (L1210 leukemia). The proportions of different types of aberrations, mainly chromatid gaps, chromatid exchanges, and acentric chromosome fragments, are similar in both the in vivo and in vitro experiments. A small proportion of cells, particularly after drug exposure for 24 hours, show extensively damaged or pulverized chromosomes. In in vitro experiments using HeLa cells and amsacrine together with two analogs of amsacrine with differing cytotoxic activity, an inverse relationship between the frequency of chromosomal aberrations and cell survival has been demonstrated. The results are consistent with the proposal that for this class of drugs, the induction of chromosomal aberrations, both in vivo and in vitro, leads to cell death.
抗肿瘤药物安吖啶在培养细胞(L1210小鼠白血病细胞和HeLa细胞)以及体内(L1210白血病)中均可引起染色体畸变。在体内和体外实验中,不同类型畸变的比例,主要是染色单体间隙、染色单体交换和无着丝粒染色体片段,是相似的。一小部分细胞,特别是在药物暴露24小时后,显示出广泛受损或粉碎的染色体。在使用HeLa细胞和安吖啶以及两种具有不同细胞毒性活性的安吖啶类似物进行的体外实验中,已证明染色体畸变频率与细胞存活之间呈负相关。这些结果与以下提议一致,即对于这类药物,体内和体外染色体畸变的诱导都会导致细胞死亡。